The TBXT rs2305089 SNP links the benign notochordal cell tumour and chordoma
The Journal of Pathology · 2025
DOI: 10.1002/path.6427 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2025. Verfasst von Inga Usher und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University College London Cancer Institute, London, UK. Hauptthemen laut MEDLINE: Chordoma, Polymorphism, Single Nucleotide, Notochord, Bone Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Surgeons of England, National Institute for Health and Care Research, Pathological Society of Great Britain and Ireland.
Abstract (Originalsprache)
The aim of this research was to investigate the pathogenesis of the bone cancer chordoma and the role of the germline rs2305089 SNP in TBXT . Using medical imaging and genotyping studies, we observed that benign notochordal cell tumours (BNCTs) were associated with chordomas and with the variant rs2305089 A‐allele with enrichment of the AA genotype compared to controls. We engineered in vitro mesoderm models, representing notochord, which showed higher expression of TBXT and activation of its regulatory network in the presence of the variant A allele. Heterozygotes (GA) displayed enrichment of Wnt/β‐catenin and epithelial mesenchymal transition pathways, faster cell migratory capacity, and altered expression of endoplasmic reticulum and intracellular transport mediators. WT lines (GG) were enriched for metabolic pathways and MTORC1 signalling, suggesting that rs2305089 genotype regulates notochord vacuoles during notochord regression. By leveraging patient‐derived data and functional studies, we show that the variant rs2305089 A‐allele predisposes to BNCTs and ultimately to chordomas. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University College London Cancer Institute, London, UK.
- Victor Horsley Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, London, UK.
- Department of Musculoskeletal Radiology, Royal National Orthopaedic Hospital, Stanmore, UK.
- Department of Cancer Biology, University College London Cancer Institute, London, UK.
- Department of Radiology, University Hospital Basel, Switzerland.
- Department of Radiology, Royal Prince Alfred Hospital, Sydney, Australia.
ORCID-Profile: Inga Usher, Paul O'Donnell, Paul Cool, Lucia Cottone, Adrienne M Flanagan
Förderung
- Royal College of Surgeons of England
- National Institute for Health and Care Research
- Pathological Society of Great Britain and Ireland
- Bone Cancer Research Trust
Zitieren
APA
Usher, I., O'Donnell, P., Ligammari, L., Harder, D., Brown, W., Choi, D., Cool, P., Cottone, L., & Flanagan, A. M. (2025). The TBXT rs2305089 SNP links the benign notochordal cell tumour and chordoma. The Journal of Pathology. https://doi.org/10.1002/path.6427
Vancouver
Usher I, O'Donnell P, Ligammari L, Harder D, Brown W, Choi D, et al. The TBXT rs2305089 SNP links the benign notochordal cell tumour and chordoma. The Journal of Pathology. 2025. doi:10.1002/path.6427
BibTeX
@article{Usher2025,
author = {Usher, Inga and O'Donnell, Paul and Ligammari, Lorena and Harder, Dorothee and Brown, Wendy and Choi, David and Cool, Paul and Cottone, Lucia and Flanagan, Adrienne M},
title = {The TBXT rs2305089 SNP links the benign notochordal cell tumour and chordoma},
journal = {The Journal of Pathology},
year = {2025},
doi = {10.1002/path.6427}
}
EUVIMED